John Micek - Mar 28, 2022 Form 4 Insider Report for Jaguar Health, Inc. (JAGX)

Role
Director
Signature
/s/ Steven R. King, Attorney-in-Fact
Stock symbol
JAGX
Transactions as of
Mar 28, 2022
Transactions value $
$0
Form type
4
Date filed
3/30/2022, 09:38 PM
Previous filing
May 20, 2021
Next filing
May 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAGX Restricted stock units Award $0 +85.9K $0.00 85.9K Mar 28, 2022 Common Stock 85.9K Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the issuer's 2014 Stock Incentive Plan.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock unit grants were approved by the issuer's board of directors on March 28, 2022.
F4 The restricted stock units vest in full on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice.